CALLI VANLANGENDONCK: Open Payments
NPI 1205408275 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 5 payments from 3 companies in 2025. Trend: 2023 $73 · 2024 $201 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $71 |
| UROGEN PHARMA, INC. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $28 |
Products named: GEMTESA, ERLEADA.
Industry payments across LA — which companies pay providers there.
